~21 spots leftby Apr 2026

FLACS vs Standard Phacoemulsification for Cataracts

Recruiting in Palo Alto (17 mi)
GD
Overseen byGeorges Durr, MD, FRCSC
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Recruiting
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)
No Placebo Group

Trial Summary

What is the purpose of this trial?

The main goal of this study is to compare traditional cataract surgery with two new technologies: the femtosecond laser and the new Active Sentry handpiece. The femtosecond laser is used in several fields of ophthalmology and allows to automate multiple key steps of cataract surgery. The new generation of handpiece called Active Sentry has the particularity to detect the pressure inside the eye in real time and to adjust it to avoid large variations. Theses technologies would potentially increase the efficacy and safety of standard cataract surgery. This study therefore aims at evaluating the differences in cumulative dissipated energy and endothelial cell loss between femtosecond laser assisted cataract surgery with the new Active Sentry handpiece compared to standard phaco with new (Active Sentry) or older handpieces (OZil).

Research Team

GD

Georges Durr, MD, FRCSC

Principal Investigator

Centre hospitalier de l'Université de Montréal (CHUM)

Eligibility Criteria

This trial is for adults over 18 who need cataract surgery with lens implantation and can consent to participate. They must be able to attend all study visits. It's not for those under 18, unable to consent or follow-up, having additional eye surgeries, past ocular surgeries, irregular corneal astigmatism/keratoconus, or other eye diseases.

Inclusion Criteria

Ability to provide informed consent;
I am having a straightforward cataract surgery with lens replacement.
Ability to be followed for the entire duration of the study.
See 1 more

Exclusion Criteria

I have eye conditions other than cataracts.
I have had eye surgery in the past.
I cannot commit to the full duration of the study.
See 4 more

Treatment Details

Interventions

  • Femtosecond laser assisted cataract surgery with Active Sentry handpiece (Device)
  • Standard phacoemulsification with the Active Sentry handpiece (Procedure)
  • Standard phacoemulsification with the OZil handpiece (Procedure)
Trial OverviewThe study compares traditional cataract surgery against two newer technologies: femtosecond laser-assisted surgery using the Active Sentry handpiece and standard phacoemulsification with either the new Active Sentry or older OZil handpieces. The focus is on energy used during surgery and health of corneal cells afterwards.
Participant Groups
3Treatment groups
Experimental Treatment
Group I: Standard phacoemulsification with the OZil handpieceExperimental Treatment1 Intervention
Participants suffering from cataract who are candidates for standard phacoemulsification with the traditional OZil handpiece
Group II: Standard phacoemulsification with the Active Sentry handpieceExperimental Treatment1 Intervention
Participants suffering from cataract who are candidates for standard phacoemulsification with the new Active Sentry handpiece
Group III: Femtosecond laser assisted cataract surgery with Active Sentry handpieceExperimental Treatment1 Intervention
Participants suffering from cataract who are candidates for femtosecond laser assisted cataract surgery

Find a Clinic Near You

Research Locations NearbySelect from list below to view details:
Centre Hospitalier de l'Université de MontréalMontréal, Canada
Loading ...

Who Is Running the Clinical Trial?

Centre hospitalier de l'Université de Montréal (CHUM)

Lead Sponsor

Trials
389
Patients Recruited
143,000+